29
Views
3
CrossRef citations to date
0
Altmetric
Perspective

Prevention or promotion of dryness and eczema by moisturizers?

Pages 667-676 | Published online: 10 Jan 2014

References

  • Kiebert G, Sorensen SV, Revicki D et al. Atopic dermatitis is associated with a decrement in health-related quality of life. Int. J. Dermatol.41(3), 151–158 (2002).
  • Su JC, Kemp AS, Varigos GA, Nolan TM. Atopic eczema: its impact on the family and financial cost. Arch. Dis. Child.76(2), 159–162 (1997).
  • Beattie PE, Lewis-Jones MS. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br. J. Dermatol.155(1), 145–151 (2006).
  • Anderson RT, Rajagopalan R. Effects of allergic dermatosis on health-related quality of life. Curr. Allergy Asthma Rep.1(4), 309–315 (2001).
  • Bender BG, Leung SB, Leung DY. Actigraphy assessment of sleep disturbance in patients with atopic dermatitis: an objective life quality measure. J. Allergy Clin. Immunol.111(3), 598–602 (2003).
  • Reid P, Lewis-Jones MS. Sleep difficulties and their management in preschoolers with atopic eczema. Clin. Exp. Dermatol.20(1), 38–41 (1995).
  • Fivenson D, Arnold RJ, Kaniecki DJ, Cohen JL, Frech F, Finlay AY. The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organization. J. Manag. Care Pharm.8(5), 333–342 (2002).
  • Palmer CN, Irvine AD, Terron-Kwiatkowski A et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet.38(4), 441–446 (2006).
  • Weidinger S, Illig T, Baurecht H et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J. Allergy Clin. Immunol.118(1), 214–219 (2006).
  • Morar N, Cookson WO, Harper JI, Moffatt MF. Filaggrin mutations in children with severe atopic dermatitis. J. Invest. Dermatol.127(7), 1667–1672 (2007).
  • Rawlings AV, Harding CR. Moisturization and skin barrier function. Dermatol. Ther.17(Suppl 1.), 43–48 (2004).
  • Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat. Rev. Mol. Cell Biol.6(4), 328–340 (2005).
  • Lodén M, Olsson H, Axell T, Linde YW. Friction, capacitance and transepidermal water loss (TEWL) in dry atopic and normal skin. Br. J. Dermatol.126(2), 137–141 (1992).
  • Werner Y, Lindberg M. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm. Venereol.65(2), 102–105 (1985).
  • Loden M, Buraczewska I, Halvarsson K. Facial anti-wrinkle cream: influence of product presentation on effectiveness: a randomized and controlled study. Skin Res. Technol.13(2), 189–194 (2007).
  • Lewis-Jones S, Mugglestone MA. Management of atopic eczema in children aged up to 12 years: summary of NICE guidance. BMJ335(7632), 1263–1264 (2007).
  • Burr S. Emollients for managing dry skin conditions. Prof. Nurse15(1), 43–48 (1999).
  • Holden C, English J, Hoare C et al. Advised best practice for the use of emollients in eczema and other dry skin conditions. J. Dermatolog. Treat.13(3), 103–106 (2002).
  • Howlett S. Emotional dysfunction, child–family relationships and childhood atopic dermatitis. Br. J. Dermatol.140(3), 381–384 (1999).
  • Buraczewska I, Berne B, Lindberg M, Torma H, Loden M. Changes in skin barrier function following long-term treatment with moisturizers, a randomized controlled trial. Br. J. Dermatol.156(3), 492–498 (2007).
  • Held E, Sveinsdottir S, Agner T. Effect of long-term use of moisturizer on skin hydration, barrier function and susceptibility to irritants. Acta Derm. Venereol.79(1), 49–51 (1999).
  • Zachariae C, Held E, Johansen JD, Menne T, Agner T. Effect of a moisturizer on skin susceptibility to NiCl2. Acta Derm. Venereol.83(2), 93–97 (2003).
  • Elias PM, Wood LC, Feingold KR. Epidermal pathogenesis of inflammatory dermatoses. Am. J. Contact Dermat.10(3), 119–126 (1999).
  • Lodén M, Maibach HI. Dry Skin and Moisturizers: Chemistry and Function. CRC Press, FL, USA 1–543 (2000).
  • Aungst BJ. The influence of fatty acids and fatty alcohols on skin permeability. In: Dry Skin and Moisturizers: Chemistry and Function. Maibach HI (Ed.). CRC Press, FL, USA 299–325 (2000).
  • Barany E, Lindberg M, Lodén M. Unexpected skin barrier influence from nonionic emulsifiers. Int. J. Pharm.195(1–2), 189–195 (2000).
  • Kibbe AW. Handbook of Pharmaceutical Excipients. American Pharmaceutical Association, Pharmaceutical Press, Washington, DC, USA (2000).
  • Lundstrom A, Egelrud T. Cell shedding from human plantar skin in vitro: evidence of its dependence on endogenous proteolysis. J. Invest. Dermatol.91(4), 340–343 (1988).
  • De Groot AC. Sensitizing substances. In: Dry Skin and Moisturizers: Chemistry and Function. Maibach HI (Ed.). CRC Press, FL, USA 403–411 (2000).
  • Kezic S, Kemperman PM, Koster ES et al. Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum. J. Invest. Dermatol.128(8), 2117–2119 (2008).
  • Scott IR, Harding CR. Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environment. Dev. Biol.115, 84–92 (1986).
  • Laden K, Spitzer R. Identification of a natural moisturizing agent in skin. J. Soc. Cosm. Chem.18, 351–360 (1967).
  • Laden K. Natural moisturization factors in skin. Am. Perfum. Cosmet.82, 77–79 (1967).
  • Imokawa G, Kuno H, Kawai M. Stratum corneum lipids serve as a bound-water modulator. J. Invest. Dermatol.96(6), 845–851 (1991).
  • Middleton J. Development of a skin cream designed to reduce dry and flaky skin. J. Soc. Cosmet. Chem.25, 519–534 (1974).
  • Jokura Y, Ishikawa S, Yamasaki S, Imokawa G. Solid state 13C-NMR studies on elastic property of the stratum corneum. Presented at: 17th International IFSCC Congress. Yokohama, 13–16 October 1992.
  • Jacobi OK. Moisture regulation in the skin. Drug Cosmet. Ind.84, 732–812 (1959).
  • Nakagawa N, Sakai S, Matsumoto M et al. Relationship between NMF (lactate and potassium) content and the physical properties of the stratum corneum in healthy subjects. J. Invest. Dermatol.122(3), 755–763 (2004).
  • Yoneya T, Nishijima Y. Determination of free glycerol on human skin surface. Biomed. Mass Spectrom.6(5), 191–193 (1979).
  • Horii I, Nakayama Y, Obata M, Tagami H. Stratum corneum hydration and amino acid content in xerotic skin. Br. J. Dermatol.121, 587–592 (1989).
  • Sybert VP, Dale BA, Holbrook KA. Ichthyosis vulgaris: identification of a defect in filaggrin synthesis correlated with an absence of keratohyaline granules. J. Invest. Dermatol.84, 191–194 (1985).
  • Marstein S, Jellum E, Eldjarn L. The concentration of pyroglutamic acid (2-pyrrolidone-5-carboxylic acid) in normal and psoriatic epidermis, determined on a microgram scale by gas chromatography. Clin. Chim. Acta43, 389–395 (1973).
  • Vahlquist A. Ichthyosis – an inborn dryness and scaliness of the skin. In: Dry Skin and Moisturizers: Chemistry and Function. Maibach HI (Ed.). CRC Press, FL, USA 83–94 (2000).
  • Wellner K, Wohlrab W. Quantitative evaluation of urea in stratum corneum of human skin. Arch. Dermatol. Res.285, 239–240 (1993).
  • Fluhr JW, Mao-Qiang M, Brown BE et al. Glycerol regulates stratum corneum hydration in sebaceous gland deficient (asebia) mice. J. Invest. Dermatol.120(5), 728–737 (2003).
  • Mattai J, Froebe CL, Rhein LD et al. Prevention of model stratum corneum lipid phase transitions in vitro by cosmetic additives – differential scanning calometry, optical microscopy, and water evaporation studies. J. Soc. Cosmet. Chem.44, 89–100 (1993).
  • Froebe CL, Simion FA, Ohlmeyer H et al. Prevention of stratum corneum lipid phase transitions in vitro by glycerol – an alternative mechanism for skin moisturization. J. Soc. Cosmet. Chem.41, 51–65 (1990).
  • Costa-Balogh FO, Wennerstrom H, Wadso L, Sparr E. How small polar molecules protect membrane systems against osmotic stress: the urea–water–phospholipid system. J. Phys. Chem.110(47), 23845–23852 (2006).
  • Rawlings AV, Harding C, Watkinson A, Banks J, Ackerman C, Sabin R. The effect of glycerol and humidity on desmosome degradation in stratum corneum. Arch. Dermatol. Res.287, 457–464 (1995).
  • Alderson SG, Barratt MG, Black JG. Effect of 2-hydroxyacids on guinea-pig footpad stratum corneum: mechanical properties and binding studies. Int. J. Cosmet. Sci.6, 91 (1984).
  • Takahashi M, Machida Y, Tsuda Y. The influence of hydroxy acids on the rheological properties of stratum corneum. J. Soc. Cosmet. Chem.36, 177–187 (1985).
  • Hall KJ, Hill JC. The skin plasticisation effect of 2-hydroxyoctanoic acid. 1: the use of potentiators. J. Soc. Cosmet. Chem.37, 397–407 (1986).
  • Jokura Y, Ishikawa S, Tokuda H, Imokawa G. Molecular analysis of elastic properties of the stratum corneum by solid-state 13C-nuclear magnetic resonance spectroscopy. J. Invest. Dermatol.104(5), 806–812 (1995).
  • Ghadially R, Halkier-Sorensen L, Elias PM. Effects of petrolatum on stratum corneum structure and function. J. Am. Acad. Dermatol.26(3 Pt 2), 387–396 (1992).
  • Moloney SJ. The in vitro percutaneous absorption of glycerol trioleate through hairless mouse skin. J. Pharm. Pharmacol.40, 819–821 (1988).
  • Wertz PW, Downing DT. Metabolism of topically applied fatty acid methyl esters in BALB/C mouse epidermis. J. Derm. Sci.1, 33–38 (1990).
  • Dewsbury CE, Graham P, Darley CR. Topical eicosapentaenoic acid (EPA) in the treatment of psoriasis. Br. J. Dermatol.120, 581 (1989).
  • Escobar SO, Achenbach R, Innantuono R, Torem V. Topical fish oil in psoriasis – a controlled and blind study. Clin. Exp. Dermatol.17, 159–162 (1992).
  • Tollesson A, Frithz A. Borage oil, an effective new treatment for infantile seborrhoeic dermatitis. Br. J. Dermatol.129(1), 95 (1993).
  • Tollesson A, Frithz A. Transepidermal water loss and water content in the stratum corneum in infantile seborrhoeic dermatitis. Acta Derm. Venereol.73(1), 18–20 (1993).
  • Mao-Qiang M, Brown BE, Wu-Pong S, Feingold KR, Elias PM. Exogenous nonphysiologic vs physiologic lipids. Divergent mechanisms for correction of permeability barrier dysfunction. Arch. Dermatol.131(7), 809–816 (1995).
  • Rawlings AV, Conti A, Rogers J, Verdejo P, Harding CR. Seasonal influences on stratum corneum ceramide 1 linoleate content and the influence of topical essential fatty acids. Presented at: 18th International IFSCC Congress. Venice, Italy, 3–6 October 1994.
  • Miller CC, Tang W, Ziboh VA, Fletcher MP. Dietary supplementation with ethyl ester concentrates of fish oil (n-3) and borage oil (n-6) polyunsaturated fatty acids induces epidermal generation of local putative anti-inflammatory metabolites. J. Invest. Dermatol.96, 98–103 (1991).
  • Lodén M. The increase in skin hydration after application of emollients with different amounts of lipids. Acta Derm. Venereol.72(5), 327–330 (1992).
  • Lodén M, Olsson H, Skare L, Axéll T. Instrumental and sensory evaluation of the frictional response of the skin following a single application of five moisturizing creams. J. Soc. Cosmet. Chem., 43, 13–20 (1992).
  • Rawlings AV, Matts PJ. Stratum corneum moisturization at the molecular level: an update in relation to the dry skin cycle. J. Invest. Dermatol.124(6), 1099–1110 (2005).
  • Kikuchi K, Tagami H. Noninvasive biophysical assessments of the efficacy of a moisturizing cosmetic cream base for patients with atopic dermatitis during different seasons. Br. J. Dermatol.158(5), 969–978 (2008).
  • Halkier-Sorensen L, Thestrup-Pedersen K. The efficacy of a moisturizer (Locobase®) among cleaners and kitchen assistants during everyday exposure to water and detergents. Contact Derm.29(5), 266–271 (1993).
  • Vilaplana J, Coll J, Trullás C, Axón A, Pelejero C. Clinical and non-invasive evaluation of 12% ammonium lactate emulsion for the treatment of dry skin in atopic and non-atopic subjects. Acta Derm. Venereol. (Stockh.)72, 28–33 (1992).
  • Kolbe L, Kligman AM, Stoudemayer T. Objective bioengineering methods to assess the effects of moisturizers on xerotic leg of elderly people. J. Derm. Treat.11, 241–245 (2000).
  • Gånemo A, Virtanen M, Vahlquist A. Improved topical treatment of lamellar ichthyosis: a double blind study of four different cream formulations. Br. J. Dermatol.141, 1027–1032 (1999).
  • Andersson A-C, Lindberg, M., Lodén, M. The effect of two urea-containing creams on dry, eczematous skin in atopic patients. I. Expert, patient and instrumental evaluation. J. Derm. Treat.10, 165–169 (1999).
  • Grice K, Sattar H, Baker H. Urea and retinoic acid in ichthyosis and their effect on transepidermal water loss and water holding capacity of stratum corneum. Acta Derm. Venereol. (Stockh.)54, 114–118 (1973).
  • Lodén M. Barrier recovery and influence of irritant stimuli in skin treated with a moisturizing cream. Contact Derm.36(5), 256–260 (1997).
  • Lodén M, Kuzmina N, Nyrén M, Edlund F, Emtestam L. Nickel susceptibility and skin barrier function to water after treatment with a urea-containing moisturizer. Exog. Dermatol.3, 99–105 (2004).
  • Lodén M, Andersson A-C, Lindberg M. Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm®). Br. J. Dermatol.140, 264–267 (1999).
  • Lodén M. Urea-containing moisturizers influence barrier properties of normal skin. Arch. Dermatol. Res.288(2), 103–107 (1996).
  • Lodén M, Bárány E, Mandahl P, Wessman C. The influence of urea treatment on skin susceptibility to surfactant-induced irritation: a placebo-controlled and randomized study. Exog. Dermatol.3, 1–6 (2004).
  • Held E, Sveinsdottir S, Agner T. Effect of long-term use of moisturizers on skin hydration, barrier function and susceptibility to irritants. Acta Derm. Venereol. (Stockh.)79, 49–51 (1999).
  • Duval C, Lindberg M, Boman A, Johnsson S, Edlund F, Loden M. Differences among moisturizers in affecting skin susceptibility to hexyl nicotinate, measured as time to increase skin blood flow. Skin Res. Technol.9(1), 59–63 (2003).
  • Tree S, Marks R. An explanation for the ‘placebo’ effect of bland ointment bases. Br. J. Dermatol.92, 195–198 (1975).
  • Buraczewska I, Brostrom U, Loden M. Artificial reduction in transepidermal water loss improves skin barrier function. Br. J. Dermatol.157(1), 82–86 (2007).
  • Caussin J, Groenink HW, de Graaff AM et al. Lipophilic and hydrophilic moisturizers show different actions on human skin as revealed by cryo scanning electron microscopy. Exp. Dermatol16(11), 891–898 (2007).
  • Potts RO, Francoeur ML. The influence of stratum corneum morphology on water permeability. J. Invest. Dermatol.96, 495–499 (1991).
  • Rougier A, Lotte C, Corcuff P, Maibach HI. Relationship between skin permeability and corneocyte size according to anatomic site, age, and sex in man. J. Soc. Cosmet. Chem.39, 15–26 (1988).
  • Buraczewska I, Berne B, Lindberg M, Lodén M, Törmä H. Long-term treatment with moisturizers affects keratinocyte differentiation and desquamation on the mRNA level. Arch. Dermatol. Res. (2008) (Epub ahead of print).
  • Lindberg M, Forslind B. The skin as a barrier. In: Dry Skin and Moisturizers: Chemistry and Function. Maibach HI (Ed.). CRC Press, FL, USA 9–21 (2005).
  • Crowther JM, Sieg A, Blenkiron P et al. Measuring the effects of topical moisturizers on changes in stratum corneum thickness, water gradients and hydration in vivo. Br. J. Dermatol.159(3), 567–577 (2008).
  • Lodén M, Barany E, Mandahl P, Wessman C. The influence of urea-treatment on skin susceptibility to surfactant-induced irritation. A placebo-controlled and randomized study. Exog. Dermatol.3, 1–6 (2004).
  • Chamlin SL, Kao J, Frieden IJ et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J. Am. Acad. Dermatol.47(2), 198–208 (2002).
  • Man MM, Feingold KR, Thornfeldt CR, Elias PM. Optimization of physiological lipid mixtures for barrier repair. J. Invest. Dermatol.106(5), 1096–1101 (1996).
  • Fluhr JW, Gloor M, Lehmann L, Lazzerini S, Distante F, Berardesca E. Glycerol accelerates recovery of barrier function in vivo. Acta Derm. Venereol.79(6), 418–421 (1999).
  • Berardesca E, Barbareschi M, Veraldi S, Pimpinelli N. Evaluation of efficacy of a skin lipid mixture in patients with irritant contact dermatitis, allergic contact dermatitis or atopic dermatitis: a multicenter study. Contact Derm.45(5), 280–285 (2001).
  • De Paepe K, Derde M-P, Reseeuw D, Rogiers V. Incorporation of ceramide 3B in dermatocosmetic emulsions: effect of the transepidermal water loss of sodium lauryl sulphate-damaged skin. J. Eur. Acad. Dermatol. Venereol.14, 272–279 (2000).
  • Lodén M, Barany E. Skin-identical lipids versus petrolatum in the treatment of tape-stripped and detergent-perturbed human skin. Acta Derm. Venereol.80(6), 412–415 (2000).
  • Zettersten EM, Ghadially R, Feingold KR, Crumrine D, Elias PM. Optimal ratios of topical stratum corneum lipids improve barrier recovery in chronologically aged skin. J. Am. Acad. Dermatol.37, 403–408 (1997).
  • Lodén M, Andersson AC. Effect of topically applied lipids on surfactant-irritated skin. Br. J. Dermatol.134(2), 215–220 (1996).
  • Schurer NY. Implementation of fatty acid carriers to skin irritation and the epidermal barrier. Contact Derm.47(4), 199–205 (2002).
  • Sheu MY, Fowler AJ, Kao J et al. Topical peroxisome proliferator activated receptor-α activators reduce inflammation in irritant and allergic contact dermatitis models. J. Invest. Dermatol.118(1), 94–101 (2002).
  • Fowler AJ, Sheu MY, Schmuth M et al. Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production. J. Invest. Dermatol.120(2), 246–255 (2003).
  • Komuves LG, Hanley K, Jiang Y, Elias PM, Williams ML, Feingold KR. Ligands and activators of nuclear hormone receptors regulate epidermal differentiation during fetal rat skin development. J. Invest. Dermatol.111(3), 429–433 (1998).
  • Buraczewska I. Skin barrier responses to moisturizers. Acta Universitatis Upsaliensis. In: Digital Comphrensive Summaries of Uppsala Dissertations from the Faculty of Medicine. Uppsala, Sweden 381, 66 (2008).
  • Rawlings AV, Davies A, Carlomusto M et al. Effect of lactic acid isomers on keratinocyte ceramide synthesis, stratum corneum lipid levels and stratum corneum barrier function. Arch. Dermatol. Res.288, 383–390 (1996).
  • Tanno O, Ota Y, Kitamura N, Katsube T, Inoue S. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. Br. J. Dermatol.143(3), 524–531 (2000).
  • Harris IR, Farrell AM, Grunfeld C, Holleran WM, Elias PM, Feingold KR. Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis. J. Invest. Dermatol.109(6), 783–787 (1997).
  • Proksch E, Elias PM, Feingold KR. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in murine epidermis. Modulation of enzyme content and activation state by barrier requirements. J. Clin. Invest.85(3), 874–882 (1990).
  • Holleran WM, Feingold KR, Man MQ, Gao WN, Lee JM, Elias PM. Regulation of epidermal sphingolipid synthesis by permeability barrier function. J. Lipid Res.32(7), 1151–1158 (1991).
  • Ottey KA, Wood LC, Grunfeld C, Elias PM, Feingold KR. Cutaneous permeability barrier disruption increases fatty acid synthetic enzyme activity in the epidermis of hairless mice. J. Invest. Dermatol.104(3), 401–404 (1995).
  • Masini E, Giannini L, Nistri S et al. Ceramide: a key signaling molecule in a Guinea pig model of allergic asthmatic response and airway inflammation. J. Pharmacol. Exp. Ther.324(2), 548–557 (2008).
  • Weinberg WC, Denning MF. P21Waf1 control of epithelial cell cycle and cell fate. Crit. Rev. Oral Biol. Med.13(6), 453–464 (2002).
  • Chang BD, Watanabe K, Broude EV et al. Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc. Natl Acad. Sci. USA97(8), 4291–4296 (2000).
  • Pigatto PD, Bigardi AS, Cannistraci C, Picardo M. 10% urea cream (Laceran®) for atopic dermatitis: a clinical and laboratory evaluation. J. Derm. Treat.7, 171–175 (1996).
  • Hagemann I, Proksch E. Topical treatment by urea reduces epidermal hyperproliferation and induces differentiation in psoriasis. Acta Derm. Venereol.76(5), 353–356 (1996).
  • Buraczewska I, Lodén M. Treatment of surfactant-damaged skin in humans with creams of different pH. Pharmacology73(1), 1–7 (2005).
  • Levin J, Maibach H. Human skin buffering capacity: an overview. Skin Res. Technol.14(2), 121–126 (2008).
  • Lucky AW, Leach AD, Laskarzewski P, Wenck H. Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr. Dermatol.14(4), 321–324 (1997).
  • Giordano-Labadie F, Cambazard F, Guillet G, Combemale P, Mengeaud V. Evaluation of a new moisturizer (Exomega milk) in children with atopic dermatitis. J. Dermatolog. Treat.17(2), 78–81 (2006).
  • Draelos ZD. The effect of ceramide-containing skin care products on eczema resolution duration. Cutis81(1), 87–91 (2008).
  • Szczepanowska J, Reich A, Szepietowski JC. Emollients improve treatment results with topical corticosteroids in childhood atopic dermatitis: a randomized comparative study. Pediatr. Allergy Immunol.19(7), 614–618 (2008).
  • Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol. Assess.4(37), 1–191 (2000).
  • Berth-Jones J, Damstra RJ, Golsch S et al. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study. BMJ326(7403), 1367 (2003).
  • Wollenberg A, Reitamo S, Girolomoni G et al. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy63(7), 742–750 (2008).
  • Meurer M, Folster-Holst R, Wozel G, Weidinger G, Junger M, Brautigam M. Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study. Dermatology205(3), 271–277 (2002).
  • Meurer M, Fartasch M, Albrecht G et al. Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis. Dermatology208(4), 365–372 (2004).
  • Gollnick H, Kaufmann R, Stough D et al. Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial. Br. J. Dermatol.158(5), 1083–1093 (2008).
  • Ghadially R, Reed JT, Elias PM. Stratum corneum structure and function correlates with phenotype in psoriasis. J. Invest. Dermatol.107(4), 558–564 (1996).
  • Motta S, Monti M, Sesana S, Mellesi L, Ghidoni R, Caputo R. Abnormality of water barrier function in psoriasis. Arch. Dermatol.130, 452–456 (1994).
  • Elias PM, Schmuth M, Uchida Y et al. Basis for the permeability barrier abnormality in lamellar ichthyosis. Exp. Dermatol.11, 248–256 (2002).
  • Lavrijsen AP, Oestmann E, Hermans J, Bodde HE, Vermeer BJ, Ponec M. Barrier function parameters in various keratinization disorders: transepidermal water loss and vascular response to hexyl nicotinate. Br. J. Dermatol.129(5), 547–553 (1993).
  • Lavrijsen AP, Bouwstra JA, Gooris GS, Weerheim A, Bodde HE, Ponec M. Reduced skin barrier function parallels abnormal stratum corneum lipid organization in patients with lamellar ichthyosis. J. Invest. Dermatol.105(4), 619–624 (1995).
  • Broberg A, Svensson Å, Borres MP, Berg R. Atopic dermatitis in 5–6-year-old Swedish children: cumulative incidence, point prevalence, and severity scoring. Allergy55, 1025–1029 (2000).
  • Larsen FS, Diepgen T, Svensson Å. The occurence of atopic dermatitis in North Europe: an international questionnaire study. J. Am. Acad. Dermatol.34, 760–764 (1996).
  • Taieb A. Hypothesis: from epidermal barrier dysfunction to atopic disorders. Contact Derm.41(4), 177–180 (1999).
  • Lodén M, Wessman C. The influence of a cream containing 20% glycerin and its vehicle on skin barrier properties. Int. J. Cosm. Sci.23, 115–120 (2001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.